TriSalus Life Sciences, Inc. TLSI Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $56.55M+324% | $20.79M+134% | $23.04M+97.9% | $26.84M+59.5% | $13.35M+209% | ||
| —— | $400K+14.3% | $350K0.0% | $350K0.0% | $350K0.0% | ||
| $5.22M-4.4% | $6.56M+28.6% | $5M+1.8% | $5.57M+18.4% | $5.45M+27.5% | ||
| $3.78M-9.2% | $3.08M-24.0% | $3.28M-18.1% | $3.81M+10.6% | $4.16M+42.9% | ||
| $1.32M-21.2% | $1.29M-3.7% | $1.42M+14.2% | $1.67M+85.8% | $1.67M+111% | ||
| $2.6M+3.3% | $1.9M-30.3% | $1.94M-29.9% | $2.19M-13.7% | $2.52M+18.5% | ||
| $68.14M+172% | $32.24M+56.0% | $33.33M+40.0% | $38.08M+36.3% | $25.1M+90.3% | ||
| $1.94M-1.3% | $1.81M+8.3% | $1.83M+0.4% | $1.71M-6.5% | $1.97M+0.2% | ||
| $830K-27.0% | $861K-28.8% | $890K-37.6% | $1.1M-1.8% | $1.14M-4.9% | ||
| $69K-83.7% | $418K-1.2% | $419K-1.2% | $419K-1.2% | $424K0.0% | ||
| $70.98M+148% | $35.33M+47.4% | $36.46M+32.7% | $41.32M+27.4% | $28.63M+60.0% | ||
| $4.23M+50.8% | $3M+32.0% | $3.78M+162% | $1.9M-3.7% | $2.81M+19.5% | ||
| $269K-36.9% | $234K-38.9% | $224K-31.9% | $221K-24.1% | $426K+63.8% | ||
| —— | $128K-5.9% | —— | —— | —— | ||
| —— | $39K-50.0% | —— | —— | —— | ||
| $11.79M+0.3% | $11.5M+12.4% | $10.91M+10.0% | $9.32M-22.3% | $11.75M-18.3% | ||
| $33.08M+4.4% | $33.05M+49.6% | $32.76M+51.1% | $32.27M+51.6% | $31.7M— | ||
| —— | $81K-15.6% | —— | —— | —— | ||
| —— | $1.31M-9.2% | —— | —— | —— | ||
| —— | $42K+133% | —— | —— | —— | ||
| $58.17M-7.7% | $69.19M+38.8% | $63.19M+31.9% | $60.74M+7.4% | $63M+19.3% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| 400M0.0% | 400M+13,333,233% | 400M0.0% | 400M0.0% | 400M0.0% | ||
| $341.85M+33.8% | $296.72M+17.0% | $294.24M+18.2% | $278.79M+15.3% | $255.55M+12.7% | ||
| -$329.04M-13.5% | -$330.58M-18.3% | -$320.97M-19.1% | -$298.21M-12.1% | -$289.92M-10.8% | ||
| $12.81M+137% | -$33.86M-30.8% | -$26.73M-30.8% | -$19.42M+23.1% | -$34.37M+4.6% | ||
| $70.98M+148% | $35.33M+47.4% | $36.46M+32.7% | $41.32M+27.4% | $28.63M+60.0% | ||
| $76K-48.6% | $24K-87.2% | —— | $91K— | $148K— | ||
| $76K-48.6% | $24K-87.2% | —— | $91K— | $148K— | ||
| $2.6M— | $1.9M— | —— | —— | —— | ||
| $138K+500% | $109K+990% | $76K+2,433% | $61K— | $23K-89.1% | ||
| $69K-83.7% | $418K-1.2% | $419K-1.2% | $419K-1.2% | $424K0.0% | ||
| $830K-27.0% | $861K-28.8% | $890K-37.6% | $1.1M-1.8% | $1.14M-4.9% | ||
| $830K-27.0% | $861K-28.8% | $890K-37.6% | $1.1M-1.8% | $1.14M-4.9% | ||
| $69K-83.7% | $418K-1.2% | $419K-1.2% | $419K-1.2% | $424K0.0% | ||
| $1.94M-1.3% | $1.81M+8.3% | $1.83M— | $1.71M— | $1.97M— | ||
| $830K-27.0% | $861K-28.8% | $890K-37.6% | $1.1M-1.8% | $1.14M-4.9% | ||
| $69K-83.7% | $418K-1.2% | $419K-1.2% | $419K-1.2% | $424K0.0% | ||
| $7.07M-15.9% | $8.1M+10.1% | $6.77M-14.0% | $7.08M-24.8% | $8.4M-26.4% | ||
| $7.07M-15.9% | $8.1M+10.1% | $6.77M-14.0% | $7.08M-24.8% | $8.4M-26.4% | ||
| $218K+84.7% | $167K-22.7% | $129K-51.5% | $123K-61.9% | $118K-67.5% | ||
| $269K-36.9% | $234K-38.9% | $224K-31.9% | $221K-24.1% | $426K+63.8% | ||
| $9.08M-4.1% | $12.89M+55.0% | $12.78M+63.6% | $10M-20.0% | $9.46M-35.1% | ||
| $2.74M-66.6% | $10.14M+37.1% | $5M-24.0% | $7.52M-15.8% | $8.22M-63.7% | ||
| $9.08M-4.1% | $12.89M+55.0% | $12.78M+63.6% | $10M-20.0% | $9.46M-35.1% | ||
| $1.19M-8.4% | $1.23M-7.6% | $1.23M-18.3% | $1.27M+9.6% | $1.3M+6.7% | ||
| $300K-46.8% | $383K-24.5% | $502K+17.8% | $358K-49.9% | $564K— | ||
| $33.08M+4.4% | $34.44M+45.8% | $32.76M+51.1% | $32.27M+51.6% | $31.7M— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 61.4M+90.3% | 50M+59.8% | 49.9M+63.7% | 38M+39.9% | 32.3M+20.6% | ||
| 10M0.0% | 10M0.0% | 10M0.0% | 10M0.0% | 10M0.0% | ||
| 0-100% | 0-100% | 0-100% | 3.6M-10.5% | 3.6M-9.8% | ||
| 0-100% | 0-100% | 0-100% | 3.6M-10.5% | 3.6M-9.8% | ||
| $5K+66.7% | $4K+33.3% | $4K+33.3% | $3K+50.0% | $3K+50.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 7.4M0.0% | 7.4M+1.2% | 7.4M+1.2% | 7.4M-48.4% | 7.4M-47.9% | ||
| $76K— | $24K— | —— | —— | —— | ||
| $76K-48.6% | $24K-87.2% | —— | $91K— | $148K— | ||
| $7.4M0.0% | $7.4M+1.2% | $7.4M+1.2% | $7.4M-48.4% | $7.4M-47.9% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $400M0.0% | $400M0.0% | $400M0.0% | $400M0.0% | $400M0.0% | ||
| $61.41M+90.3% | $50M+59.8% | $49.89M+63.7% | $37.98M+39.9% | $32.27M+20.6% | ||
| $61.41M+90.3% | $50M+59.8% | $49.89M+63.7% | $37.98M+39.9% | $32.27M+20.6% | ||
| $9.08M-4.1% | $12.89M+55.0% | $12.78M+63.6% | $10M-20.0% | $9.46M-35.1% | ||
| —— | $39K-50.0% | —— | —— | —— | ||
| 3+50.0% | —— | 1— | 2— | 2— | ||
| 20.0% | —— | 2-50.0% | 2-50.0% | 2— | ||
| 10M+56.7% | —— | 10M+67.1% | 6.4M+7.0% | 6.4M+6.6% | ||
| —— | —— | —— | $1.4M— | $4.7M— | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $10M0.0% | $10M0.0% | $10M0.0% | $10M0.0% | $10M0.0% | ||
| $0-100% | $0-100% | $0-100% | $3.59M-10.5% | $3.62M-9.8% | ||
| $0-100% | $0-100% | $0-100% | $3.59M-10.5% | $3.62M-9.8% | ||
| $2.59M+4.5% | $2.17M-27.9% | $2.37M-34.5% | $2.22M-33.1% | $2.48M+22.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TriSalus Life Sciences, Inc.'s total assets?
- TriSalus Life Sciences, Inc. (TLSI) holds $71.0M in total assets, up 148.0% year over year.
- How much debt does TriSalus Life Sciences, Inc. have?
- TriSalus Life Sciences, Inc. carries $33.1M in total debt against $12.8M of shareholders' equity, a debt-to-equity ratio of 2.58.
- How much cash does TriSalus Life Sciences, Inc. have?
- TriSalus Life Sciences, Inc. holds $56.6M in cash and equivalents.
- Can TriSalus Life Sciences, Inc. cover its short-term obligations?
- Its current ratio is 5.78 — current assets exceed current liabilities.
- Where does TriSalus Life Sciences, Inc.'s balance sheet data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
